Symposium

Cystic Fibrosis: From Gene Discovery to Basic Biology to Precision Medicines

In honor of Francis Collins, Paul Negulescu, Bonnie Ramsey, Lap-Chee Tsui, Michael Welsh

for pioneering contributions to the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene and to the subsequent research that led to the development of transformational precision medicines to treat the underlying cause of cystic fibrosis.

Featured Speakers Include:

Francis Collins, MD, PhD
Director, National Institutes of Health
Positional Cloning in Medieval Times (1989)

Paul Negulescu, PhD
Senior Vice President, Research, Vertex Pharmaceuticals Incorporated
Fixing CFTR

Bonnie Ramsey, MD
Vice Chair and Endowed Professor of Pediatrics, University of Washington School of Medicine
Director, Center for Clinical and Translational Research, Seattle Children’s Research Institute
Journey from Bench to Bedside –The Joys and Challenges of Cystic Fibrosis Translational Research

Michael Welsh, MD
Professor, Internal Medicine and Molecular Physiology and Biophysics, University of Iowa
Investigator HHMI, Director, Pappajohn Biomedical Institute
What Does CFTR Do and How Do Mutations Cause Cystic Fibrosis?

Pamela Davis, MD, PhD
Dean, School of Medicine, and Senior Vice President for Medical Affairs, Case Western Reserve University
Cystic Fibrosis - a blueprint for future genetic diagnosis and treatment

Jay Rajagopal, MD
Professor of Medicine, Center for Regenerative Medicine, Massachusetts General Hospital
HHMI Faculty Scholar
A New Cellular Narrative of Lung Disease

RSVP: wap@hms.harvard.edu

Location:
Harvard Medical School
The Joseph B.Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115

Open to the Public

Seating is not reserved and is available on a first come first served basis.